Literature DB >> 16301621

RasGRP1 and RasGRP3 regulate B cell proliferation by facilitating B cell receptor-Ras signaling.

Jason J Coughlin1, Stacey L Stang, Nancy A Dower, James C Stone.   

Abstract

The RasGRPs are a family of Ras activators that possess diacylglycerol-binding C1 domains. In T cells, RasGRP1 links TCR signaling to Ras. B cells coexpress RasGRP1 and RasGRP3. Using Rasgrp1 and Rasgrp3 single and double null mutant mice, we analyzed the role of these proteins in signaling to Ras and Erk in B cells. RasGRP1 and RasGRP3 both contribute to BCR-induced Ras activation, although RasGRP3 alone is responsible for maintaining basal Ras-GTP levels in unstimulated cells. Surprisingly, RasGRP-mediated Ras activation is not essential for B cell development because this process occurs normally in double-mutant mice. However, RasGRP-deficient mice do exhibit humoral defects. Loss of RasGRP3 led to isotype-specific deficiencies in Ab induction in immunized young mice. As reported previously, older Rasgrp1-/- mice develop splenomegaly and antinuclear Abs as a result of a T cell defect. We find that such mice have elevated serum Ig levels of several isotypes. In contrast, Rasgrp3-/- mice exhibit hypogammaglobulinemia and show no signs of splenomegaly or autoimmunity. Double-mutant mice exhibit intermediate serum Ab titers, albeit higher than wild-type mice. Remarkably, double-mutant mice exhibit no signs of autoimmunity or splenomegaly. B cell proliferation induced by BCR ligation with or without IL-4 was found to be RasGRP1- and RasGRP3-dependent. However, the RasGRPs are not required for B cell proliferation per se, because LPS-induced proliferation is unaffected in double-mutant mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301621     DOI: 10.4049/jimmunol.175.11.7179

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  70 in total

1.  Molecular characterization of in vivo adjuvant activity in ferrets vaccinated against influenza virus.

Authors:  Yuan Fang; Thomas Rowe; Alberto J Leon; David Banner; Ali Danesh; Luoling Xu; Longsi Ran; Steven E Bosinger; Yi Guan; Honglin Chen; Cheryl C Cameron; Mark J Cameron; David J Kelvin
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

Review 2.  Molecular underpinning of B-cell anergy.

Authors:  Yuval Yarkoni; Andrew Getahun; John C Cambier
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

3.  Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells.

Authors:  Husheng Ding; Jennifer S McDonald; Seongseok Yun; Paula A Schneider; Kevin L Peterson; Karen S Flatten; David A Loegering; Ann L Oberg; Shaun M Riska; Shengbing Huang; Frank A Sinicrope; Alex A Adjei; Judith E Karp; X Wei Meng; Scott H Kaufmann
Journal:  Haematologica       Date:  2013-08-30       Impact factor: 9.941

4.  RasGRP3 contributes to formation and maintenance of the prostate cancer phenotype.

Authors:  Dazhi Yang; Noemi Kedei; Luowei Li; Juan Tao; Julia F Velasquez; Aleksandra M Michalowski; Balázs I Tóth; Rita Marincsák; Attila Varga; Tamás Bíró; Stuart H Yuspa; Peter M Blumberg
Journal:  Cancer Res       Date:  2010-09-28       Impact factor: 12.701

5.  BLNK binds active H-Ras to promote B cell receptor-mediated capping and ERK activation.

Authors:  Yasuhiro Imamura; Akihisa Oda; Takashi Katahira; Kenji Bundo; Kelly A Pike; Michael J H Ratcliffe; Daisuke Kitamura
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

6.  Ras GEF Mouse Models for the Analysis of Ras Biology and Signaling.

Authors:  Alberto Fernández-Medarde; Eugenio Santos
Journal:  Methods Mol Biol       Date:  2021

7.  Novel Mutations in RASGRP1 are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma.

Authors:  Ido Somekh; Benjamin Marquardt; Yanshan Liu; Meino Rohlfs; Sebastian Hollizeck; Musa Karakukcu; Ekrem Unal; Ebru Yilmaz; Turkan Patiroglu; Murat Cansever; Shirly Frizinsky; Vicktoria Vishnvenska-Dai; Erez Rechavi; Tali Stauber; Amos J Simon; Atar Lev; Christoph Klein; Daniel Kotlarz; Raz Somech
Journal:  J Clin Immunol       Date:  2018-07-20       Impact factor: 8.317

Review 8.  Lipid rafts and B cell signaling.

Authors:  Neetu Gupta; Anthony L DeFranco
Journal:  Semin Cell Dev Biol       Date:  2007-07-24       Impact factor: 7.727

9.  Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas.

Authors:  Matthew J Frank; David W Dawson; Steven J Bensinger; Jason S Hong; Wendy M Knosp; Lizhong Xu; Cynthia E Balatoni; Eric L Allen; Rhine R Shen; Dafna Bar-Sagi; Gail R Martin; Michael A Teitell
Journal:  Blood       Date:  2009-01-15       Impact factor: 22.113

10.  Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus.

Authors:  Jian-Wen Han; Hou-Feng Zheng; Yong Cui; Liang-Dan Sun; Dong-Qing Ye; Zhi Hu; Jin-Hua Xu; Zhi-Ming Cai; Wei Huang; Guo-Ping Zhao; Hong-Fu Xie; Hong Fang; Qian-Jin Lu; Jian-Hua Xu; Xiang-Pei Li; Yun-Feng Pan; Dan-Qi Deng; Fan-Qin Zeng; Zhi-Zhong Ye; Xiao-Yan Zhang; Qing-Wen Wang; Fei Hao; Li Ma; Xian-Bo Zuo; Fu-Sheng Zhou; Wen-Hui Du; Yi-Lin Cheng; Jian-Qiang Yang; Song-Ke Shen; Jian Li; Yu-Jun Sheng; Xiao-Xia Zuo; Wei-Fang Zhu; Fei Gao; Pei-Lian Zhang; Qing Guo; Bo Li; Min Gao; Feng-Li Xiao; Cheng Quan; Chi Zhang; Zheng Zhang; Kun-Ju Zhu; Yang Li; Da-Yan Hu; Wen-Sheng Lu; Jian-Lin Huang; Sheng-Xiu Liu; Hui Li; Yun-Qing Ren; Zai-Xing Wang; Chun-Jun Yang; Pei-Guang Wang; Wen-Ming Zhou; Yong-Mei Lv; An-Ping Zhang; Sheng-Quan Zhang; Da Lin; Yi Li; Hui Qi Low; Min Shen; Zhi-Fang Zhai; Ying Wang; Feng-Yu Zhang; Sen Yang; Jian-Jun Liu; Xue-Jun Zhang
Journal:  Nat Genet       Date:  2009-10-18       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.